Supporting the Country in Times of Crisis — and Every Day
Healthcare distributors have been integrally engaged in COVID-19 related response efforts, working with federal, state and local government agencies to distribute medical supplies, PPE, therapeutics and vaccines to all Americans — from the biggest cities to the smallest towns.
Featured StoryFive Lessons Learned From the COVID-19 Response Effort
Navigating the Exceptional Demands of the Nationwide Vaccine Rollout
McKesson is the centralized distributor of COVID-19 vaccines through the federal government; AmerisourceBergen, Cardinal Health and Morris & Dickson are supporting vaccine distribution in key states; and AmerisourceBergen is the primary distributor of all COVID-19 related therapeutics authorized for emergency use by the Food and Drug Administration.
AmerisourceBergen, Cardinal Health and McKesson are serving as network administrators in the Federal Retail Pharmacy Program for COVID-19 Vaccination.
AmerisourceBergen is playing a critical role in enabling redistribution of COVID-19 vaccines by partnering with multiple state departments of health, a manufacturer and the U.S. government to lead an innovative program that delivers smaller quantities of vaccines to providers who would not have otherwise had access.
And through their logistics expertise, HDA members are now finding the most efficient ways to reliably deliver novel COVID-19 therapeutics, antivirals and boosters, as directed by the federal government.
HDA distributors are committed to the public- and private-sector partnerships that are critical in combating COVID-19, fueling our recovery, and improving pandemic resiliency for the future.
HDA members cover the entire country and have established relationships with federal agencies and closely coordinate with state public health departments.
Supporting the Strategic National Stockpile
AmerisourceBergen is working directly with the Strategic National Stockpile (SNS) to store, manage and distribute medicines. They are helping to restructure and resupply the stockpile so that there are enough medicines in the event of future COVID-19 surges or other public health crises. McKesson also has a contract with the SNS to manage the assembly of ancillary supply kits needed to administer all COVID-19 vaccines.Learn More
The First 90 Days
During the early stages of COVID-19, the pharmaceutical supply chain — powered by distributors — quickly adapted and adjusted to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients. Distributors are leveraging lessons learned from this initial response effort during the unprecedented nationwide vaccine rollout:
- The private sector is a crucial partner;
- Responding to supply challenges requires adaptation; and,
- Coordination across the supply chain is essential.